QNCX ▲ +3.8% - Quince Therapeutics, Inc.
$QNCX - Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
09-OCT-2026 08:00 AM ET
Share this post
More filings for $QNCX
QNCX ▲ +2.5% - Quince Therapeutics, Inc.Sep 17, 2026QNCX ▼ -1.4% - Quince Therapeutics, Inc.Sep 3, 2026QNCX - Quince Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026QNCX - Quince Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026QNCX - Quince Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$QNCX SEC Filing Update (10-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 10, 2026
View full $QNCX filing history →💬 Comments
Loading comments…
Leave a comment